Conversation 158: Resapp technology now in clinical use in COVID-19 fight.

Following a one month trial at a federally funded COVID-19 respiratory clinic in Queensland, ResApp Health Limited's (ASX: RAP), ResAppDx-EU smartphone app has been put into clinical use.

Health Hub Doctors Morayfield was the first respiratory clinic established with federal government funding to take pressure off local hospitals by treating mild-moderate respiratory illnesses and assessing patients requiring COVID-19 testing. What impact will this have on the stock?